Exploratory Study to Investigate the Bioactivity, Ocular and Systemic Safety, Tolerability, and Pharmacokinetics Following Single and Multiple Intravitreal Administrations of KSI-301 in Subjects With wAMD, DME and RVO
Clinical trial NCT03790852 · TERMINATED
Trial details
- NCT number
- NCT03790852
- Sponsor
- Kodiak Sciences Inc
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-26
- Primary completion
- 2021-06-02
- Enrollment
- 121
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.